Gore's Viabil biliary stent approved in Canada
This article was originally published in Clinica
The Viabil biliary endoprosthesis developed by W L Gore (Flagstaff, Arizona) has received approval from Health Canada. The device is intended for the treatment of benign or malignant biliary strictures, and can be removed up to 12 months after implantation. Biliary strictures can be caused by surgical injury, cancer of the bile duct, or damage due to gallstones and pancreatitis. The self-expanding stent works as a barrier against tumour ingrowth and tissue attachment. Viabil will be sold in Canada by ConMed Canada.